These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32084270)
1. Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts. Galgoczi E; Jeney F; Katko M; Erdei A; Gazdag A; Sira L; Bodor M; Berta E; Ujhelyi B; Steiber Z; Gyory F; Nagy EV Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):27. PubMed ID: 32084270 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts. Galgoczi E; Molnar Z; Katko M; Ujhelyi B; Steiber Z; Nagy EV Chem Biol Interact; 2024 Jun; 396():111045. PubMed ID: 38729283 [TBL] [Abstract][Full Text] [Related]
3. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy. Yoon Y; Chae MK; Lee EJ; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1095-1102. PubMed ID: 31900640 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves' Orbitopathy. Galgoczi E; Katko M; Papp FR; Csiki R; Csiha S; Erdei A; Bodor M; Ujhelyi B; Steiber Z; Gyory F; Nagy EV Molecules; 2022 Dec; 28(1):. PubMed ID: 36615214 [TBL] [Abstract][Full Text] [Related]
5. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487 [TBL] [Abstract][Full Text] [Related]
6. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts. Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769 [TBL] [Abstract][Full Text] [Related]
7. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts. Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902 [TBL] [Abstract][Full Text] [Related]
8. Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Dai G; Freudenberger T; Zipper P; Melchior A; Grether-Beck S; Rabausch B; de Groot J; Twarock S; Hanenberg H; Homey B; Krutmann J; Reifenberger J; Fischer JW Am J Pathol; 2007 Nov; 171(5):1451-61. PubMed ID: 17982124 [TBL] [Abstract][Full Text] [Related]
9. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor. Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810 [TBL] [Abstract][Full Text] [Related]
11. Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation. Steen EH; Short WD; Li H; Parikh UM; Blum A; Templeman N; Nagy N; Bollyky PL; Keswani SG; Balaji S Drug Deliv; 2021 Dec; 28(1):422-432. PubMed ID: 33605181 [TBL] [Abstract][Full Text] [Related]
12. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662 [No Abstract] [Full Text] [Related]
15. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
16. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells. Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148 [TBL] [Abstract][Full Text] [Related]
17. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Li L; Asteriou T; Bernert B; Heldin CH; Heldin P Biochem J; 2007 Jun; 404(2):327-36. PubMed ID: 17324121 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts. Guo N; Woeller CF; Feldon SE; Phipps RP J Biol Chem; 2011 May; 286(21):18856-67. PubMed ID: 21454487 [TBL] [Abstract][Full Text] [Related]
19. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. Guo N; Baglole CJ; O'Loughlin CW; Feldon SE; Phipps RP J Biol Chem; 2010 May; 285(21):15794-804. PubMed ID: 20308056 [TBL] [Abstract][Full Text] [Related]
20. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity. Qin J; Kilkus J; Dawson G Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]